PepGen Inc. SEC filings PEPG
PepGen Inc. has 304 filings in SEC EDGAR's recent list, going back to Dec 9, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Aug 6, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| EFFECT | Filing | May 21, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 21, 2026 | May 21, 2026 |
| CORRESP | Letter to the SEC | May 19, 2026 | — |
| S-3 | Shelf registration | May 18, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 18, 2026 |
| UPLOAD | Letter from the SEC | Apr 17, 2026 | — |
| DRS | Filing | Apr 15, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2026 | Mar 4, 2026 |
| S-8 | Employee stock plan registration | Mar 4, 2026 | — |
| 10-K | Annual report | Mar 4, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Other events
|
Dec 8, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 7, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 26, 2025 | Sep 24, 2025 |
| 424B5 | Prospectus supplement | Sep 25, 2025 | — |
| 424B5 | Prospectus supplement | Sep 24, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 24, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 28, 2025 | May 28, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 31, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 28, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Other events
|
Mar 4, 2025 | Mar 4, 2025 |
| S-8 | Employee stock plan registration | Feb 24, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 24, 2025 | Feb 24, 2025 |
| 10-K | Annual report | Feb 24, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Jan 29, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Other events
|
Oct 8, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 19, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Other events
|
Aug 20, 2024 | Aug 20, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 30, 2024 | Jul 30, 2024 |
| EFFECT | Filing | Jul 8, 2024 | — |
| CORRESP | Letter to the SEC | Jul 3, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2024 | — |
| 8-K |
Current report
Other events
|
Jul 2, 2024 | Jul 2, 2024 |
| S-3 | Shelf registration | Jun 28, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Other events
|
Jun 11, 2024 | Jun 11, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| DEFA14A | Additional proxy material | May 1, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 20, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2024 | Jun 20, 2024 |
| 10-K/A | Amended annual report | Mar 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 15, 2024 | Mar 15, 2024 |
| 8-K |
Current report
Other events
|
Mar 13, 2024 | Mar 13, 2024 |
| S-8 | Employee stock plan registration | Mar 6, 2024 | — |
| 10-K | Annual report | Mar 6, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2024 | Mar 6, 2024 |
| 8-K |
Current report
Other events
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Other events
|
Feb 20, 2024 | Feb 20, 2024 |
| 424B5 | Prospectus supplement | Feb 7, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 7, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Other events
|
Jan 17, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Other events
|
Dec 18, 2023 | Dec 18, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 15, 2023 | Nov 15, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Other events
|
Oct 12, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Other events
|
Sep 6, 2023 | Sep 6, 2023 |
| 8-K |
Current report
Other events
|
Sep 6, 2023 | Sep 6, 2023 |
| 424B5 | Prospectus supplement | Aug 8, 2023 | — |
| 8-K |
Current report
Material agreement
|
Aug 8, 2023 | Aug 8, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2023 | Jun 22, 2023 |
| EFFECT | Filing | Jun 16, 2023 | — |
| CORRESP | Letter to the SEC | Jun 14, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 13, 2023 | Jun 13, 2023 |
| UPLOAD | Letter from the SEC | Jun 9, 2023 | — |
| S-3 | Shelf registration | Jun 2, 2023 | — |
| 8-K |
Current report
Other events
|
May 30, 2023 | May 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 18, 2023 | May 18, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2023 | Mar 27, 2023 |
| S-8 | Employee stock plan registration | Mar 23, 2023 | — |
| 10-K | Annual report | Mar 23, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Other events
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Other events
|
Dec 7, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Other events
|
Nov 14, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2022 | Sep 28, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 22, 2022 | Sep 20, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2022 | Aug 12, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2022 | Jul 22, 2022 |
| 10-Q | Quarterly report | Jun 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
Jun 16, 2022 | Jun 16, 2022 |
| SEC STAFF LETTER | Filing | May 16, 2022 | — |
| EFFECT | Filing | May 11, 2022 | — |
| S-8 | Employee stock plan registration | May 10, 2022 | — |
| POS AM | Filing | May 10, 2022 | — |
| 424B4 | Prospectus | May 9, 2022 | — |
| EFFECT | Filing | May 5, 2022 | — |
| CERT | Filing | May 5, 2022 | — |
| CORRESP | Letter to the SEC | May 4, 2022 | — |
| S-1/A | Amended registration statement | May 4, 2022 | — |
| UPLOAD | Letter from the SEC | May 3, 2022 | — |
| 8-A12B | Filing | May 3, 2022 | — |
| CORRESP | Letter to the SEC | May 3, 2022 | — |
| CORRESP | Letter to the SEC | May 3, 2022 | — |
| CORRESP | Letter to the SEC | May 2, 2022 | — |
| S-1/A | Amended registration statement | May 2, 2022 | — |
| CORRESP | Letter to the SEC | Apr 22, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2022 | — |
| S-1 | Registration statement | Apr 15, 2022 | — |
| DRSLTR | Filing | Apr 8, 2022 | — |
| DRS/A | Filing | Apr 8, 2022 | — |
| SEC STAFF LETTER | Filing | Apr 7, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2022 | — |
| DRSLTR | Filing | Feb 11, 2022 | — |
| DRS/A | Filing | Feb 11, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 28, 2021 | — |
| DRS | Filing | Oct 1, 2021 | — |
| D | Filing | Aug 6, 2021 | — |
| D | Filing | Dec 9, 2020 | — |
Showing 146 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PEPG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1835597
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.